AEON Biopharma, Inc.

US$0.18As of Sun 8 Nov 2026, 12:00 UTC
AMEX:AEONHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (77.72%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.69
PE TTM —
TSR TTM (79.31%)
Mkt cap US$8.774M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.173
(1.38%)
(96.37%)
Buy 12|10|3|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
22.66%
19.16%
14.22%
6.92%
Revenue$M
0.413
0.432
0.432
0.438
0.18%
1.66%
3.36%
6.80%
Peers (US$8.774M)
Cap (US$)
PE
9.134M
—
8.797M
—
Capital
TTM
5Y
10Y
Leveragex
0.398
0.657
0.602
EBIT/Intx
1.589
0.947
0.863
Own earn%
24.60
(85.00)
(99.14)
Sh yield%
23.73
45.51
45.41
Owners
Insiders/Inst%
1.97
83.07
Short interest%
3.86
SBC / revenue%
4.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
2